Mobile Mindfulness Meditation for Cancer-Related Anxiety and Neuropathy: Protocol for a Randomized Controlled Trial (Preprint)
Ariel Siritorn Orasud, Mai Uchiyama, Ian Pagano et al.
A randomized waitlist controlled trial is described that will test the Mindfulness Coach mobile app for cancer survivors who have finished primary treatment and experience anxiety or cancer-related neuropathy. The trial aims to enroll 400 participants (200 for each condition) and collect data at baseline, 8 weeks, and 16 weeks. Outcomes are expected in early 2024. The study will also assess pain, fatigue, trauma, sleep, and satisfaction with the app.